Atlas Trials

Human Bioequivalence Test of Liraglutide Injection

Clinical trial NCT05029076 · COMPLETED

Trial details

NCT number
NCT05029076
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2019-05-21
Primary completion
2019-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.